MedTrace Logo

rTMS Treatment in Patients With General Anxiety Disorder

NCT00616447 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-12-16

No results posted yet for this study

Summary

This study will compare the change detected by a standardized rating scale (Hamilton Anxiety Rating Scale) scores in the active treatment group as compared to sham (placebo) group after 6 weeks of rTMS treatments. It is hoped that 6 weeks of rTMS treatment will lead to improvement of core symptoms in patients with GAD.

Conditions

  • Generalized Anxiety Disorder

Interventions

DEVICE

Repetitive transcranial magnetic stimulation

6 weeks of repetitive transcranial magnetic stimulation . Treatment comprises of stimulation with rTMS frequency 20Hz, intensity 110% of MT, 20 trains, 9 sec/train, 51 sec ITI applied over right dorsolateral prefrontal cortex by a figure eight shaped coil. Treatment will be given 5 times a week for 4 weeks, 3 times a week during Week 5 and 2 times a week during Week 6.

DEVICE

placebo sham

Sham treatment will mimic active treatment mentioned above.

Sponsors & Collaborators

  • Military Medical Academy, Bulgaria

    collaborator OTHER

  • Queen's University

    lead OTHER

Principal Investigators

  • Roumen Milev, MD · Queen's University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Bulgaria
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00616447 on ClinicalTrials.gov